Researchers in Denmark aim to find new solutions in the fight against antibiotic resistance
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Oct-2026 22:16 ET (24-Oct-2026 02:16 GMT/UTC)
A new understanding of antibiotic resistance could transform the diagnosis and treatment of humans and animals and help combat the global threat of antibiotic resistance more effectively.
Three new BD² Discovery Research teams will explore how external risk factors trigger manic or depressive episodes. Research led by scientists and clinicians at Harvard Medical School, Johns Hopkins University, and Stanford University will offer new insights and potential treatments for people with bipolar disorder.
A new RFA for Discovery Research focused on women’s health is now taking applications, with up to $5 million available per grant.
A research team led by Professor Dong Zhang and Guangyong Sun at Beijing Chao-Yang Hospital has identified IFITM1 as a key regulator of the potent anti-tumor activity of TCRαβ+CD4-CD8- double-negative T cells (DNTs). IFITM1 recruits p62/SQSTM1 to mitochondria and promotes mitophagy, thereby preserving mitochondrial homeostasis, energy metabolism and the tumor-killing capacity of DNTs.
Three teams from Bangladesh, Indonesia, and Thailand clinched prizes at the second edition of the Asia-Pacific Global Health Innovation Hackathon, held in Singapore from 18 to 19 September 2026. Jointly co-hosted by two SingHealth Duke-NUS Academic Medical Centre (AMC) institutes, the Academic Medicine Innovation Institute (AMII) and the Global Health Institute (SDGHI), alongside SingHealth's International Collaboration Office (ICO), this year’s edition brought together 13 teams from across Asia to develop transformative and scalable solutions to one of the region's most pressing public health challenges: maternal and child nutrition.
The book examines AI-powered medical imaging, surgical planning, real-time augmented reality guidance, robotics-assisted interventions and adaptive AI-AR systems for personalized care. It also explores ethical considerations, cybersecurity and regulatory frameworks, supported by practical case studies demonstrating clinical applications and future directions in precision surgery.
The Gut-Brain Nexus: The Link Between Gut Microbiota and Neurodegenerative Diseases brings together current scientific evidence and clinical perspectives to explore this emerging field. The book examines how the gut microbiota may influence neurological health and discusses mechanisms through which changes in the microbiome may contribute to disease onset and progression.